Abstract

Centaurea species are used in eastern Mediterranean ethnopharmacology as a result of varietes of bioactive compounds they comprise. Aim of this work was to characterize the Centaurea rupestris L. hydrodistilled essential oil chemical composition and test the biological activity: antimicrobial effect, antioxidant potential and inhibition of cholinesterases. Plant material authentication was done with chromosome number counting and genome size assessment with the flow cytometry. Hydrodistilled essential oils were characterised with gas chromatography/mass spectrometry technique GC-MS and GC-FID. The antimicrobial effect was tested using disk diffusion and microdilution methods methods, antioxidant potential was tested with DPPH and FRAP methods and cholinesterases inhibition was tested with Ellman method. Genome size for C. rupestris species: sample A presented 2C=3.60 (0.10) pg and sample B 2C=3.62 (0.08) pg. The chromosome number was 2n=20 for both samples. The main essential oil constituents in isolated sample A oil, detected with GC-MS and GC-FID were: germacrene D (24.3%), heptacosane (14.4%), phytol (6.7%), β- caryophyllene (5.0%) and pentacosane (4.5%). Sample B essential oil had the main constituents: hexadecanoic acid (18.7%), heptacosane (13.8%), α-linolenic acid (11.8%), nonacosane (7.8%) and germacrene D (5.4%). Both samples of oil showed broad spectrum antimicrobial effect with good activity against emerging Gram-positive and Gram- negative oportunistic pathogens and pathogenic fungi which indicates the pharmaceutical potential of the C. rupestris essential oil.

Highlights

  • D UE to an antibiotic resistance, around 700 000 people worldwide are each year threatened and killed by drug-resistant microbes

  • We aim to investigate the antimicrobial activity of Centaurea rupestris L. essential oil (EO) targeting the nosocomial pathogens included in the notorious multidrug resistant ‘ESKAPE’ group (Enterococcus spp., Staphylococcus aureus, Klebsiella spp., Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) that effectively evade the therapeutic effects of antibacterial drugs.[3]

  • We aim to study the antioxidant potential and inhibition of cholinesterase of these EOs to evaluate this aspect of biological activity of C. rupestris essential oil

Read more

Summary

Introduction

D UE to an antibiotic resistance, around 700 000 people worldwide are each year threatened and killed by drug-resistant microbes. The World Health Organization (WHO) released a list of 12 drugs - resistant bacteria or bacterial families for which new antimicrobial agents are needed. This presents the top priority in this area of science.[1]. Interests in natural products as a source of identification and development of antibacterial agents have historically been of crucial importance. Interests in natural compounds have increased due to rapid development of resistant bacterial strains. This forced reevaluation of natural products as a source of novel chemical skeletons with antibacterial activity for elaboration in drug development.[2]

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call